Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tetsuyoshi Umeno is active.

Publication


Featured researches published by Tetsuyoshi Umeno.


Acta Oto-laryngologica | 2002

Cricoid Area of the Larynx: Its Physiological and Pathological Significance

Kiminori Sato; Tetsuyoshi Umeno; Minoru Hirano; Tadashi Nakashima

The three-dimensional distribution of the cricoid area was investigated using computer graphics and its histological structure and pathology were studied using whole-organ serial sections. A total of 26 adult human larynges were examined. The findings were as follows: 1. Cricoid areas were located along the superior portion of the cricoid arch on both sides. 2. The cricoid area was surrounded by the perichondrium of the cricoid cartilage, the conus elasticus and the fibrous layer of the subglottic mucosa. 3. The cricoid area was a loose areolar area, mainly composed of adipose tissue and loose elastic and collagenous fibers. 4. Many vessels were present in the cricoid area and a superficial branch of the cricothyroid artery ran through it. 5. Vessels in the cricoid area penetrated the anteroinferior portion of the conus elasticus and extended into the prelaryngeal region. 6. In larynges with laryngeal carcinoma, cancer invasion into the cricoid area and intravascular tumor invasion facilitated metastasis to the prelaryngeal, pretracheal and/or paratracheal regions and stomal recurrence. Cricoid areas were related to the growth pattern of laryngeal cancer.


Auris Nasus Larynx | 2001

Laboratory data and treatment outcomes of head and neck tumor patients in the elderly.

Ryu Kusaba; Kikuo Sakamoto; Kazunori Mori; Tetsuyoshi Umeno; Tadashi Nakashima

OBJECTIVE To elicit the factors influencing the choice of treatment and the prognosis of elderly patients, we studied the clinical and laboratory data of head and neck tumor patients. The patients were divided into two groups (group A: younger than 75, group B: 75 years of age or older) and the treatment outcomes as well as the features of the laboratory data were analyzed. METHODS The clinical records of 1350 patients (888 males, 462 females) with head and neck tumors who received their initial treatment at our hospital were reviewed. The collected data including age, the site of the primary lesion, pre-treatment health states, pre-operative laboratory results were examined. According to the treatment policy, we grouped the patients according to whether or not they had received the standard therapy for the disease and then analyzed their treatment outcomes. RESULTS Standard therapy was not performed in 62 (5.6%) of the 1114 patients in group A and in 43 (18.2%) of the 236 patients in group B. A further analysis performed in group B (elderly patients) revealed that standard therapy was performed in 193 patients, while 43 received non-standard therapy. The prognosis for the non-standard therapy cases was poor. The averages of the laboratory test findings between groups A and B were compared, but no marked differences were observed. However, differences were observed in the ratio of patients whose data were in the normal range between group A and group B. When the laboratory data were compared between the standard and non-standard groups of the elderly, serum albumin and CBC (especially hemoglobin) showed a close relationship to the treatment modality. CONCLUSION The ratio of patients who did not receive standard therapy was high in the age group of 75 years or older. The prognosis of patients with head and neck tumors is therefore considered to depend on whether or not a patient receives the standard therapy against the disease. The pre-treatment clinical data and the laboratory findings vary markedly among elderly patients 75 years of age or older. Regarding the treatment of head and neck tumors in the elderly, the laboratory data and clinical conditions of each individual patient should be checked carefully and every possible means should be employed in order to allow such patients to receive the standard therapy whenever possible.


Nippon Jibiinkoka Gakkai Kaiho | 2000

Laser Debulking Surgery prior to Radiotherapy for T1T2 Carcinoma of the Hypopharynx

Kazunori Mori; Keiichi Chijiwa; Hirohito Umeno; Tetsuyoshi Umeno; Kikuo Sakamoto


THE LARYNX JAPAN | 1999

Conservation Treatment for T1^|^middot;T2 Carcinoma of the Larynx

Kazunori Mori; Hirohito Umeno; Keiichi Chijiwa; Tetsuyoshi Umeno; Atsushi Kikuchi; Tadashi Nakashima


Nihon Kikan Shokudoka Gakkai Kaiho | 2001

A Clinicopathological Study of Stomal Recurrence Following Total Laryngectomy.

Tetsuyoshi Umeno; Kiminori Sato; Youichi Matsuda; Gengo Ishii; Tadashi Nakashima


THE LARYNX JAPAN | 2000

Treatment Modality for Lymph Node Metastasis of the Elderly Patients with the Laryngeal Carcinoma

Keiichi Chijiwa; Tetsuyoshi Umeno; Hirohito Umeno; Kazunori Mori; Tadashi Nakashima


Nippon Jibiinkoka Gakkai Kaiho | 2000

Nasopharyngeal Stenosis after Uvulopalatopharyngoplasty

Tetsuyoshi Umeno; Kazunori Mori; Tadashi Nakasima


Practica oto-rhino-laryngologica | 1995

CO2 Laser Surgery and Radiation Therapy for Ti Glottic Carcinoma

Naomi Uchida; Shigejiro Kurita; Shinji Sakaguchi; Hidetaka Matsuoka; Tetsuyoshi Umeno; Shoichi Kashiwazi; Shinsuke Ito; Minoru Hirano


Practica oto-rhino-laryngologica | 2001

A Clinical Study of Malignant Head and Neck Tumors in Juvenile Patients

Hirohito Umeno; Youichi Matsuda; Kazunori Mori; Keiichi Chijiwa; Tetsuyoshi Umeno; Tadashi Nakashima


Practica oto-rhino-laryngologica | 2000

Origin of Laryngeal Carcinoma. A Review and Immunohistological Observation.

Tadashi Nakashima; Kiminori Satoh; Tetsuyoshi Umeno

Collaboration


Dive into the Tetsuyoshi Umeno's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge